Chinese Journal of Antituberculosis ›› 2025, Vol. 47 ›› Issue (5): 629-638.doi: 10.19982/j.issn.1000-6621.20240592
• Original Articles • Previous Articles Next Articles
Huang Huimin1,2, Wang Lei2, Cheng Liping2, Sun Qin2, Wang Wenjuan1(), Yang Hua1,2(
)
Received:
2024-12-27
Online:
2025-05-10
Published:
2025-04-29
Contact:
Yang Hua,Email: yanghua97065@163.com;Wang Wenjuan,Email:reality0337@126.com
E-mail:reality0337@126.com;yanghua97065@163.com
Supported by:
CLC Number:
Huang Huimin, Wang Lei, Cheng Liping, Sun Qin, Wang Wenjuan, Yang Hua. Study on the association between single nucleotide polymorphisms in TMEM173,IFNGR1,IFNGR2, and IRF8 genes and susceptibility to tuberculosis[J]. Chinese Journal of Antituberculosis, 2025, 47(5): 629-638. doi: 10.19982/j.issn.1000-6621.20240592
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20240592
基因tagSNP | 染色体位置 | HWE-P值 | MAF | 等位基因 |
---|---|---|---|---|
MB21D1 | ||||
rs4032696 | 6:73423989 | 0.360 | 0.267 | T:A |
rs311678 | 6:73425293 | 0.346 | 0.311 | T:C |
rs7761170 | 6:73443175 | 0.767 | 0.170 | G:T |
rs610913 | 6:73445623 | 0.884 | 0.489 | G:T |
TMEM173 | ||||
rs13153461 | 5:139472784 | 0.517 | 0.430 | G:A |
rs7380824 | 5:139477397 | 0.273 | 0.344 | C:T |
IFNB1 | ||||
rs3885423 | 9:21075676 | 0.606 | 0.186 | T:C |
rs967102 | 9:21076183 | 0.663 | 0.344 | C:G |
rs10964831 | 9:21078376 | 0.836 | 0.140 | A:T |
rs1424855 | 9:21078816 | 0.421 | 0.167 | G:C |
rs10811465 | 9:21080519 | 0.077 | 0.318 | T:C |
IFNGR1 | ||||
rs7759040 | 6:137196354 | 0.901 | 0.400 | A:T |
rs3799488 | 6:137198643 | 0.127 | 0.190 | T:C |
rs1327475 | 6:137215318 | 0.362 | 0.100 | G:A |
rs2234711 | 6:137219383 | 0.758 | 0.500 | G:A |
IFNGR2 | ||||
rs2284553 | 21:33404389 | 0.738 | 0.433 | G:A |
rs2300372 | 21:33412149 | 0.920 | 0.156 | C:T |
rs9808753 | 21:33415005 | 0.738 | 0.433 | A:G |
rs2834211 | 21:33417501 | 0.415 | 0.209 | T:C |
rs1059293 | 21:33437386 | 0.336 | 0.128 | T:C |
IRF3 | ||||
rs7251 | 19:49659652 | 0.211 | 0.367 | C:G |
rs2304206 | 19:49665614 | 0.106 | 0.198 | G:A |
rs2304204 | 19:49665763 | 0.962 | 0.256 | T:C |
IRF8 | ||||
rs191022 | 16:85898526 | 0.940 | 0.337 | C:G |
rs188602 | 16:85898745 | 0.388 | 0.116 | C:T |
rs2270501 | 16:85899382 | 0.330 | 0.221 | C:T |
rs182511 | 16:85904050 | 0.454 | 0.389 | C:G |
rs305080 | 16:85908168 | 0.146 | 0.256 | C:T |
rs2292980 | 16:85911470 | 0.859 | 0.395 | T:C |
rs925994 | 16:85912411 | 0.336 | 0.163 | C:A |
rs424971 | 16:85912844 | 0.669 | 0.465 | C:T |
rs16939967 | 16:85915867 | 0.058 | 0.226 | G:T |
rs4843860 | 16:85917315 | 0.307 | 0.279 | A:G |
rs9926411 | 16:85918051 | 0.914 | 0.434 | A:G |
rs8064189 | 16:85918190 | 0.160 | 0.456 | G:T |
rs2280378 | 16:85919139 | 0.647 | 0.500 | G:A |
rs9927932 | 16:85919840 | 0.313 | 0.138 | C:T |
rs10514611 | 16:85921636 | 0.556 | 0.178 | C:T |
rs1568391 | 16:85921698 | 0.744 | 0.174 | T:G |
rs1044873 | 16:85922065 | 0.202 | 0.372 | C:T |
rs1021479 | 16:85923808 | 0.083 | 0.395 | T:C |
rs305073 | 16:85924187 | 0.368 | 0.211 | T:C |
rs8052521 | 16:85925123 | 0.257 | 0.389 | T:C |
基因tagSNP | 观察组 [例数(构成比,%)] | 对照组 [例数(构成比,%)] | χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
IFNGR2 | |||||
rs9808753 | |||||
A | 318(55.6) | 558(57.6) | 1.000 | ||
G | 254(44.4) | 410(42.4) | 0.616 | 0.432 | 1.087(0.883~1.339) |
AA | 83(29.1) | 171(35.4) | 1.000 | ||
AG | 152(53.1) | 216(44.6) | 4.758 | 0.029 | 1.450(1.038~2.025) |
GG | 51(17.8) | 97(20.0) | 0.134 | 0.715 | 1.083(0.706~1.663) |
IRF8 | |||||
rs8064189 | |||||
G | 307(53.7) | 580(59.9) | 1.000 | ||
T | 265(46.3) | 388(40.1) | 5.743 | 0.017 | 1.290(1.047~1.590) |
GG | 81(28.3) | 171(35.3) | 1.000 | ||
GT | 145(50.7) | 238(49.2) | 2.166 | 0.141 | 1.286(0.920~1.799) |
TT | 60(21.0) | 75(15.5) | 5.744 | 0.017 | 1.689(1.098~2.597) |
rs8052521 | |||||
T | 342(59.8) | 623(64.4) | 1.000 | ||
C | 230(40.2) | 345(35.6) | 3.208 | 0.073 | 1.214(0.982~1.502) |
TT | 104(36.3) | 194(40.1) | 1.000 | ||
CT | 134(46.9) | 235(48.5) | 0.144 | 0.704 | 1.064(0.773~1.463) |
CC | 48(16.8) | 55(11.4) | 4.454 | 0.035 | 1.628(1.033~2.565) |
基因tagSNP | 显性 | 隐性 | 超显性 | |||
---|---|---|---|---|---|---|
OR(95%CI)值 | P值 | OR(95%CI)值 | P值 | OR(95%CI)值 | P值 | |
IRF8 | ||||||
rs8064189 | 1.231(0.999~1.517) | 0.047 | 1.249(1.007~1.549) | 0.062 | 0.962(0.801~1.157) | 0.709 |
rs8052521 | 1.105(0.912~1.339) | 0.320 | 1.306(1.037~1.645) | 0.037 | 1.044(0.868~1.255) | 0.655 |
IFNGR2 | ||||||
rs9808753 | 1.204(0.979~1.480) | 0.081 | 0.912(0.715~1.164) | 0.508 | 0.807(0.671~0.970) | 0.025 |
基因tagSNP | 观察组 [例数(构成比,%)] | 对照组 [例数(构成比,%)] | χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
TMEM173 | |||||
rs7380824 | |||||
CC | 104(36.4) | 207(42.8) | 1.000 | ||
CT | 141(49.3) | 209(43.2) | 3.308 | 0.069 | 1.343(0.977~1.846) |
TT | 41(14.3) | 68(14.0) | 0.622 | 0.430 | 1.200(0.763~1.889) |
IFNGR2 | |||||
rs9808753 | |||||
AA | 83(29.0) | 171(35.3) | 1.000 | ||
AG | 152(53.2) | 216(44.6) | 4.758 | 0.029 | 1.450(1.038~2.025) |
GG | 51(17.8) | 97(20.1) | 0.134 | 0.715 | 1.083(0.706~1.663) |
IRF8 | |||||
rs9926411 | |||||
AA | 132(46.1) | 206(42.6) | 1.000 | ||
AG | 130(45.5) | 218(45.0) | 0.209 | 0.647 | 0.931(0.684~1.266) |
GG | 24(8.4) | 60(12.4) | 3.172 | 0.075 | 0.624(0.371~1.051) |
rs8064189 | |||||
GG | 81(28.3) | 171(35.3) | 1.000 | ||
GT | 145(50.7) | 238(49.2) | 2.166 | 0.141 | 1.286(0.920~1.799) |
TT | 60(21.0) | 75(15.5) | 5.744 | 0.017 | 1.689(1.098~2.597) |
rs10514611a | |||||
CC | 179(62.6) | 277(57.7) | 1.000 | ||
CT | 96(33.6) | 170(35.4) | 0.713 | 0.398 | 0.874(0.639~1.195) |
TT | 11(3.8) | 33(6.9) | 3.461 | 0.063 | 0.516(0.254~1.047) |
rs8052521 | |||||
TT | 104(36.3) | 194(40.1) | 1.000 | ||
CT | 134(46.9) | 235(48.5) | 0.144 | 0.704 | 1.064(0.773~1.463) |
CC | 48(16.8) | 55(11.4) | 4.454 | 0.035 | 1.628(1.033~2.565) |
变量 | β值 | s | Wald χ2值 | P值 | OR(95%CI)值 |
---|---|---|---|---|---|
TMEM173 | |||||
rs7380824 | |||||
CC(对照) | 4.842 | 0.089 | |||
CT | 0.358 | 0.165 | 4.680 | 0.031 | 1.431(1.034~1.979) |
TT | 0.098 | 0.234 | 0.176 | 0.674 | 1.103(0.697~1.745) |
IFNGR2 | |||||
rs9808753 | |||||
AA(对照) | 1.329 | 0.514 | |||
AG | 0.194 | 0.171 | 1.286 | 0.257 | 1.215(0.868~1.700) |
GG | 0.071 | 0.217 | 0.106 | 0.745 | 1.073(0.701~1.643) |
IRF8 | |||||
rs9926411 | |||||
AA(对照) | 1.009 | 0.604 | |||
AG | 0.091 | 0.218 | 0.174 | 0.677 | 1.095(0.714~1.679) |
GG | -0.173 | 0.379 | 0.209 | 0.647 | 0.841(0.400~1.768) |
rs8064189 | |||||
GG(对照) | 2.250 | 0.325 | |||
GT | 0.124 | 0.304 | 0.167 | 0.683 | 1.132(0.624~2.054) |
TT | 0.629 | 0.470 | 1.790 | 0.181 | 1.876(0.746~4.714) |
rs10514611 | |||||
CC(对照) | 3.306 | 0.192 | |||
CT | -0.195 | 0.207 | 0.891 | 0.345 | 0.822(0.548~1.234) |
TT | -0.750 | 0.413 | 3.300 | 0.069 | 0.472(0.210~1.061) |
rs8052521 | |||||
TT(对照) | 0.602 | 0.740 | |||
CT | -0.178 | 0.254 | 0.489 | 0.484 | 0.837(0.509~1.377) |
CC | -0.266 | 0.408 | 0.425 | 0.515 | 0.767(0.345~1.705) |
[1] | World Health Organization.Global tuberculosis report 2024. Geneva: World Health Organization, 2024. |
[2] | Sun Z, Hornung V. cGAS-STING signaling. Curr Biol, 2022, 32(13): R730-R734. doi:10.1016/j.cub.2022.05.027. |
[3] | Jin YG, Zhou H, Fan D, et al. TMEM173 protects against pressure overload-induced cardiac hypertrophy by modulating autophagy. J Cell Physiol, 2021, 236(7):5176-5192. doi:10.1002/jcp.30223. |
[4] | Zhang R, Kang R, Tang D. The STING1 1 network regulates autophagy and cell death. Signal Transduct Target Ther, 2021, 6(1):208. doi:10.1038/s41392-021-00613-4. |
[5] |
Rayamajhi M, Humann J, Kearney S, et al. Antagonistic crosstalk between type I and Ⅱ interferons and increased host susceptibility to bacterial infections. Virulence, 2010, 1(5):418-422. doi:10.4161/viru.1.5.12787.
pmid: 21178482 |
[6] | Errami A, Bousfiha AA. Mendelian susceptibility to mycobacterial diseases: State of the puzzle. Qatar Med J, 2023, 2023(2): 25. doi:10.5339/qmj.2023.sqac.25. |
[7] | Casanova JL, MacMicking JD, Nathan CF. Interferon-γ and infectious diseases: Lessons and prospects. Science, 2024, 384(6693): eadl 2016. doi:10.1126/science.adl2016. |
[8] | 中华人民共和国国家卫生健康委员会.WS 288—2017肺结核诊断. 2017-11-09. |
[9] | Farnia P, Ghanavi J, Tabasri P, et al. The importance of single nucleotide polymorphisms in interferon gamma receptor-1 gene in pulmonary patients infected with rapid grower mycobacterium. Int J Mycobacteriol, 2016,5 Suppl 1: S210-S211. doi:10.1016/j.ijmyco.2016.09.040. |
[10] | 姜婧. TLR1和IFNGR1基因多态性与沈阳地区人群结核病易感性关系的研究. 沈阳:沈阳医学院, 2021. |
[11] | 曹雪平. 青海地区结核病易感性与NRAMP1、MBL基因多态性研究. 西宁:青海大学, 2022. |
[12] | 吴山客, 廖寅谦, 骆嘉泽, 等. P2X7和TAP2基因多态性与结核病易感关联性的家庭病例对照研究. 中国预防医学杂志, 2024, 25(10):1304-1311. doi:10.16506/j.1009-6639.2024.10.014. |
[13] | 袁乐永, 柯尊琼. HMGB1基因多态性与肺结核易感性的关系. 实用医学杂志, 2019, 35(14):2324-2328. doi:10.3969/j.issn.1006-5725.2019.14.029. |
[14] | 高灿. NFE2L2基因SNPs与结核病易感性的相关性研究. 石河子:石河子大学, 2023. |
[15] | 魏清雯, 王慧, 夏茸, 等. 人类宿主易感基因多态性与结核病和耐药结核病的相关性研究进展. 中国医药, 2022, 17(2):292-296. doi:10.3760/j.issn.1673-4777.2022.02.032. |
[16] | Ding S, Jiang T, He J, et al. Tagging single nucleotide polymorphisms in the IRF1 and IRF 8 genes and tuberculosis susceptibility. PLoS One, 2012, 7(8): e42104. doi:10.1371/journal.pone.0042104. |
[17] |
Meyer CG, Intemann CD, Förster B, et al. No significant impact of IFN-γ pathway gene variants on tuberculosis susceptibility in a West African population. Eur J Hum Genet, 2016, 24(5):748-755. doi:10.1038/ejhg.2015.172.
pmid: 26242990 |
[18] | Luo Y, Huang CC, Howard NC, et al. Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis. Nat Commun, 2024, 15(1):10393. doi:10.1038/s41467-024-54741-w. |
[1] | Tuberculosis Basic Professional Branch, Chinese Antituberculosis Association. Expert consensus on the standardization of broth microdilution method for drug susceptibility testing of Mycobacterium tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 535-545. |
[2] | Senior Department of Tuberculosis, the 8th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Basic and Clinical Speciality Committees of Tuberculosis Control Branch of China International Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of urological tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 546-558. |
[3] | Liu Qiao, Li Zhongqi, Zhu Limei, Lu Wei. Study on the status, problems and countermeasures of tuberculosis control service system in China [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 559-568. |
[4] | Liu Fangchao, Zhang Di, Mi Fengling, Li Zihui, Huang Hairong, Pan Liping, Shi Guangli, Jiang Guanglu, Pan Junhua. Construction of a biosafety management indicator system for tuberculosis clinical testing laboratories [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 569-576. |
[5] | Wu Zhuhua, Wang Yong, Lai Xiaoyu, Ji Liwei, Chen Ruiming, LYU Chunfang, Xu Liuyue, Guo Huixin, Chen Yuhui, Liang Hongdi, Liu Shengyuan, Zhong Xinguang, Chen Xunxun. Evaluation of the diagnostic performance of the MiniDock MTB Test for rapid tuberculosis detection [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 577-581. |
[6] | Yao Mingxu, Wang Zeqi, Song Ruixue, Jia Hongyan, Sun Qi, Zhang Lanyue, Du Boping, Zhang Zongde, Wang Wen, Wu Liang, Pan Liping. The performance of Mycobacterium tuberculosis-specific antigens-induced cytokines in the diagnosis of tuberculosis among HIV-infected individuals [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 605-612. |
[7] | Cheng Wen, Zhu Hui, Fu Lei, Zhang Weiyan, Zhang Liqun, Lu Yu. Development and application of an HPLC-MS/MS method for simultaneous determination of bedaquiline, pretomanid, and linezolid in plasma [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 613-622. |
[8] | Zhao Lingjuan, Liu Haoran, Nie Wenjuan, Wang Wei. A preliminary study on the role of miRNA-451a in the pathogenesis of disseminated tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 623-628. |
[9] | Hu Yijun, Xu Yiting, Jian Ronghua, Wu Huizhong, Su Jing, Xiao Jianpeng, Jiang Chenqi, Liu Tao, Wang Jiawen, Chen Liang. Spatio-temporal analysis and risk assessment of multidrug-resistant tuberculosis in Guangdong Province, 2014—2019 [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 639-646. |
[10] | Li Ting, Xia Lan, Liu Shuang, Wang Danxia, Lu Jia, Yu Yifan, Cheng Qianqian. Short-term effect analysis of intervention measures to strengthen patient registration management in tuberculosis designated medical institutions at provincial and municipal levels in Sichuan Province [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 647-652. |
[11] | Wang Lei, Chen Chidao, Su Lianzheng, Li Lingwei, Wang Xinmiao, Wang Peng, Huang Zhonghao. Causality between coronavirus disease 2019 and tuberculosis in Europeans: a two-sample Mendelian randomization study [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 653-659. |
[12] | Yang Tingyu, Sarina , Wang Furong, Chen Chen, Zheng Lanbing. Research progress of nanomaterials in the treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 660-665. |
[13] | Wang Yuanning, Du Zongmin. Research progress on CRISPR/Cas molecular diagnosis of drug-resistant Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(5): 666-672. |
[14] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[15] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||